Floatz logo

Mtr-601

Muscle Spasticity

Motric BioPhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Muscle Spasticity cohort.

Asset / SponsorPhaseRating
Xeomin®
Izmir Katip Celebi University
Phase 4BBB
Baclofen
Vanderbilt University
Phase 4BB
Botox-A®
The Catholic University of Korea
Phase 4BB
Coretox®
Medy-Tox
Phase 3BB
Meditoxin
Medy-Tox
Phase 4BB

View all 13 →

Same molecule, other indications

Mtr-601 is also rated in:

spinal cord injuryDormant
CC
Indicative ·
47 / 100
View asset →
dystonic disorderDormant
CC
Indicative ·
47 / 100
View asset →
cerebral palsyDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →